Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Ectopic Expression Of Mir-125a Inhibits The Proliferation And Metastasis Of Hepatocellular Carcinoma By Targeting Mmp11 And Vegf

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

MiR-125b Loss Activated HIF1/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma

Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

The Clinicopathological Significance of Decreased Mir-125B-5p in Hepatocellular Carcinoma: Evidence Based on RT-qPCR, Microrna-Microarray, and Microrna-Sequencing

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

MicroRNA-125b Suppressesed Human Liver Cancer Cell Proliferation and Metastasis by Directly Targeting Oncogene LIN28B2

MiR-125b Attenuates Human Hepatocellular Carcinoma Malignancy Through Targeting SIRT6.

Down-regulation of Microrna-125B-2-3p is a Risk Factor for a Poor Prognosis in Hepatocellular Carcinoma

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

MicroRNA Mir-124-3p Suppresses Proliferation and Epithelial–mesenchymal Transition of Hepatocellular Carcinoma Via ARRDC1 (arrestin Domain Containing 1)

MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

MicroRNA‐125a‐5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

MiR-875-5p Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Repressing Astrocyte Elevated Gene-1 (AEG-1) Expression

Upregulated Mir-1269 In Hepatocellular Carcinoma And Its Clinical Significance

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

MiR-126-3p Suppresses Tumor Metastasis and Angiogenesis of Hepatocellular Carcinoma by Targeting LRP6 and PIK3R2